This article is
- freely available
State of the Art in Tumor Antigen and Biomarker Discovery
INSERM U624, 163 avenue de Luminy, 13288 Marseille Cedex 09, France
* Author to whom correspondence should be addressed.
Received: 6 April 2011; in revised form: 24 May 2011 / Accepted: 27 May 2011 / Published: 9 June 2011
Abstract: Our knowledge of tumor immunology has resulted in multiple approaches for the treatment of cancer. However, a gap between research of new tumors markers and development of immunotherapy has been established and very few markers exist that can be used for treatment. The challenge is now to discover new targets for active and passive immunotherapy. This review aims at describing recent advances in biomarkers and tumor antigen discovery in terms of antigen nature and localization, and is highlighting the most recent approaches used for their discovery including “omics” technology.
Keywords: tumor antigen; biomarkers; immunotherapy; cancer; proteomics
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Even-Desrumeaux, K.; Baty, D.; Chames, P. State of the Art in Tumor Antigen and Biomarker Discovery. Cancers 2011, 3, 2554-2596.
Even-Desrumeaux K, Baty D, Chames P. State of the Art in Tumor Antigen and Biomarker Discovery. Cancers. 2011; 3(2):2554-2596.
Even-Desrumeaux, Klervi; Baty, Daniel; Chames, Patrick. 2011. "State of the Art in Tumor Antigen and Biomarker Discovery." Cancers 3, no. 2: 2554-2596.